Literature DB >> 2845197

Radiotherapy and L-triiodothyronine in the treatment of high-grade astrocytoma.

P Morales1, A Bosch, R Lopez, C Nery, F Borras, M Rosa.   

Abstract

From January 1983 to March 1984, eight patients with high-grade astrocytoma received postoperative irradiation concomitantly with triiodothyronine at the Radiation Therapy Department of the I. González Martínez Oncologic Hospital in San Juan, Puerto Rico. There were no complications related to treatment. One patient is alive without evidence of disease at 39 months and seven patients died with disease, one of whom lived for 3 yr. The survival curve for these patients is similar to the survival curve of 18 patients treated at the University of Chicago by surgery, radiation, and triiodothyronine. The value of triiodothyronine as an adjuvant in the treatment of high grade astrocytoma should be further investigated.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845197     DOI: 10.1002/jso.2930390210

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  3 in total

Review 1.  Neuro-oncology index and review (adult primary brain tumors). Radiotherapy, chemotherapy, immunotherapy, photodynamic therapy.

Authors:  M S Mahaley
Journal:  J Neurooncol       Date:  1991-10       Impact factor: 4.130

2.  Association of thyroid hormone concentrations with quality of life of primary brain tumor patients: a pilot study.

Authors:  Adomas Bunevicius; Edward R Laws; Vytenis Deltuva; Arimantas Tamasauskas
Journal:  J Neurooncol       Date:  2016-11-09       Impact factor: 4.130

3.  Preoperative low tri-iodothyronine concentration is associated with worse health status and shorter five year survival of primary brain tumor patients.

Authors:  Adomas Bunevicius; Vytenis Pranas Deltuva; Sarunas Tamasauskas; Timothy Smith; Edward R Laws; Robertas Bunevicius; Giorgio Iervasi; Arimantas Tamasauskas
Journal:  Oncotarget       Date:  2017-01-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.